The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients
Conditions
Critical Illness · Vitamin D Deficiency · Covid19
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
LKH Enzenbach, Enzenbach, Austria
Contact: Study coordinator (Otmar Schindler)LKH Feldbach, Feldbach, Austria
Medical University of Graz, Graz, Austria
Contact: Study coordinator (Karin Amrein, MD, MSc)Klinikum am Wörthersee, Klagenfurt, Austria
Contact: Study coordinator (Rudolf Likar, MD)LKH Hochsteiermark Standort Leoben, Leoben, Austria
Contact: Study coordinator (Viktor Wutzl)Barmherzige Schwestern, Linz, Austria
Contact: Study coordinator (Johann Reisinger, MD)Kepler Universitätsklinikum Linz, Linz, Austria
Contact: Study coordinator (Jens Meier)Krankenhaus Schwarzach, Schwarzach im Pongau, Austria
Barmherzige Brüder, Vienna, Austria
Contact: Study coordinator (Rene Schmutz, MD)Kaiser Franz Josef Spital Wien, Vienna, Austria
Medical University of Vienna, Vienna, Austria
Contact: Study coordinator (Peter Schellongowski, MD)LKH Villach, Villach, Austria
Contact: Study coordinator (Christoph Widhalm)Erasme Hospital, Brussels, Belgium
CHU de Charleroi, Charleroi, Belgium
CHR Citadelle, Liège, Belgium
CHU Ambroise Pare, Mons, Belgium
University Hospital Wuerzburg, Würzburg, Germany
Contact: Study coordinator (Patrick Meybohm, MD)University of Birmingham, Birmingham, United Kingdom
Contact: Study coordinator (Dhruv Parekh, MD)
Study leads
Karin Amrein, MD, MSc
Principal Investigator
Medical University of Graz